Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Minor layout adjustments and copy edits were detected on the Study Details page; no core study content, eligibility criteria, endpoints, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Updates present: a funding/operating status notice and a version bump to v3.2.0; removal of a specific resource entry and older revision tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T08:31:08.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The core page content shifts to the newer revision identifier, with no other substantive changes indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:03:18.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, signaling a new version release. The Back to Top link was removed, with no other substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-13T16:43:23.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T14:06:22.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to medical topics related to esophageal cancer and Parkinson's disease. Notably, previous entries related to various neoplasms and antineoplastic agents have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:04:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.